COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”

Abstract The novel coronavirus which emerged in Wuhan province of China has taken world by surprise. Since been diagnosed in December 2019, it has been termed a “Pandemic” and there is a growing concern in physicians across the globe. As new evidence is emerging, there are various preventative strat...

Full description

Bibliographic Details
Main Authors: Salman Mansoor, Siobhan Kelly, Kevin Murphy, Aine Waters, Nauman Saleem Siddiqui
Format: Article
Language:English
Published: SpringerOpen 2020-05-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41983-020-00177-0